Your browser doesn't support javascript.
loading
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.
Soo, R A; Han, J-Y; Dafni, U; Cho, B C; Yeo, C M; Nadal, E; Carcereny, E; de Castro, J; Sala, M A; Bernabé, R; Coate, L; Provencio Pulla, M; Garcia Campelo, R; Cuffe, S; Hashemi, S M S; Früh, M; Massuti, B; Garcia-Sanchez, J; Dómine, M; Majem, M; Sanchez-Torres, J-M; Britschgi, C; Pless, M; Dimopoulou, G; Roschitzki-Voser, H; Ruepp, B; Rosell, R; Stahel, R A; Peters, S.
Affiliation
  • Soo RA; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Han JY; National Cancer Center, Center for Lung Cancer, Goyang, Republic of Korea.
  • Dafni U; National and Kapodistrian University of Athens, Athens, Greece; Frontier Science Foundation Hellas, Athens, Greece.
  • Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Division of Medical Oncology, Seoul, Republic of Korea.
  • Yeo CM; Medical Oncology Department, Tan Tock Seng Hospital, Singapore, Singapore.
  • Nadal E; Medical Oncology Department, ICO L'Hospitalet, Barcelona, Spain.
  • Carcereny E; Medical Oncology Department, Institut Català d'Oncologia Badalona Hospital Germans Trias i Pujol, B-ARGO Group, Badalona, Spain.
  • de Castro J; Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain.
  • Sala MA; Medical Oncology Department, Hospital Universitario Basurto, Bilbao, Spain.
  • Bernabé R; Medical Oncology Department, Hospital Virgen del Rocio, Sevilla, Spain.
  • Coate L; Mid-Western Cancer Centre and University Hospital Limerick, Limerick, Ireland.
  • Provencio Pulla M; Hospital Puerta de Hierro, Majadahonda Medical Oncology Service, Madrid, Spain.
  • Garcia Campelo R; Medical Oncology Department, Hospital Teresa Herrera, La Coruña, Spain.
  • Cuffe S; Department of Medical Oncology, St. James's Hospital, Dublin, Ireland.
  • Hashemi SMS; Department of Pulmonary Diseases, Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands.
  • Früh M; Cantonal Hospital St. Gallen, Oncology and Hematology, St. Gallen, Switzerland; Department of Oncology, Inselspital Bern, Bern, Switzerland.
  • Massuti B; Medical Oncology Department, Hospital General Universitario Alicante, Alicante, Spain.
  • Garcia-Sanchez J; Medical Oncology Service, Hospital Arnau Vilanova, Valencia, Spain.
  • Dómine M; Department of Oncology, Hospital Universitario Fundacion Jimenez Díaz (IIS-FJD), Madrid, Spain.
  • Majem M; Medical Oncology Department, Hospital De La Santa Creu I Sant Pau, Barcelona, Spain.
  • Sanchez-Torres JM; Medical Oncology Department, Hospital Universitario de la Princesa, Madrid, Spain.
  • Britschgi C; Department of Medical Oncology and Hematology, University Hospital Zurich, Comprehensive Cancer Center Zurich, Zurich, Switzerland.
  • Pless M; Cantonal Hospital Winterthur, Oncology and Haematology, Winterthur, Switzerland.
  • Dimopoulou G; Frontier Science Foundation Hellas, Athens, Greece.
  • Roschitzki-Voser H; European Thoracic Oncology Platform (ETOP), Coordinating Office, Bern, Switzerland.
  • Ruepp B; European Thoracic Oncology Platform (ETOP), Coordinating Office, Bern, Switzerland.
  • Rosell R; Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain; Catalan Institute of Oncology (ICO), Honorary Consultant, Barcelona, Spain.
  • Stahel RA; European Thoracic Oncology Platform (ETOP), Coordinating Office, Bern, Switzerland. Electronic address: Rolf.Stahel@etop-eu.org.
  • Peters S; Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.
Ann Oncol ; 33(2): 181-192, 2022 02.
Article in En | MEDLINE | ID: mdl-34839016
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Singapore
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Singapore